Avanos Medical (NYSE:AVNS – Get Free Report) was downgraded by stock analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued on Sunday.
Avanos Medical Stock Performance
Shares of AVNS stock opened at $19.21 on Friday. The stock has a market cap of $882.89 million, a P/E ratio of 56.50 and a beta of 0.93. The company has a debt-to-equity ratio of 0.12, a current ratio of 2.22 and a quick ratio of 1.49. The company has a fifty day moving average price of $23.04 and a two-hundred day moving average price of $21.52. Avanos Medical has a one year low of $17.39 and a one year high of $25.36.
Institutional Trading of Avanos Medical
A number of hedge funds have recently modified their holdings of AVNS. Canada Pension Plan Investment Board acquired a new stake in shares of Avanos Medical during the 2nd quarter worth about $70,000. EntryPoint Capital LLC increased its position in Avanos Medical by 97.6% during the first quarter. EntryPoint Capital LLC now owns 5,601 shares of the company’s stock worth $112,000 after acquiring an additional 2,766 shares during the period. XTX Topco Ltd bought a new position in Avanos Medical during the second quarter worth about $202,000. Magnetar Financial LLC bought a new position in Avanos Medical during the second quarter worth about $248,000. Finally, Janney Montgomery Scott LLC increased its position in Avanos Medical by 19.1% during the first quarter. Janney Montgomery Scott LLC now owns 13,010 shares of the company’s stock worth $259,000 after acquiring an additional 2,082 shares during the period. Institutional investors and hedge funds own 95.17% of the company’s stock.
About Avanos Medical
Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.
Featured Articles
- Five stocks we like better than Avanos Medical
- 3 Grocery Stocks That Can Help Take a Bite Out of Inflation
- Intel: Is Now the Time to Be Brave?Â
- Breakout Stocks: What They Are and How to Identify Them
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- 3 REITs to Buy and Hold for the Long Term
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Avanos Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avanos Medical and related companies with MarketBeat.com's FREE daily email newsletter.